UK cochlear implantation outcomes in the elderly have not been previously reported to our knowledge. The aim of this study is to assess the benefits of cochlear implantation in this group so that the purchasing authorities may recognize that healthcare resources are being utilized appropriately.
Predictability of cochlear implant outcome in families
β Scribed by Anil K. Lalwani; Cameron L. Budenz; Adam S. Weisstuch; James Babb; J. Thomas Roland Jr.; Susan B. Waltzman
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 84 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives:
The purpose of this study is to determine if the performance of the first implanted member of a family predicts the performance of subsequently implanted family members.
Study Design:
Retrospective chart review.
Methods:
Seventyβone cochlear implant recipients, each belonging to a family with two or more implanted members, were the subjects of this study. Routine audiometric measurements and ageβappropriate speech perception tests were performed preβ and postoperatively. In addition, length of deafness, age at implantation, etiology, and length of device usage were correlated to outcome.
Results:
All implant recipients within a family showed improvement postimplantation, and the predictive component between family members was strong. Presence of GJB2 mutations and greater age at implantation were predictive of poorer rehabilitative outcome, while length of device usage was associated with improved speech perception scores.
Conclusions:
On average, if the first implanted family member performs well with a cochlear implant, those following will do well; however, GJB2βrelated deafness and increased age at implantation are associated with poorer outcome. These findings have important implications for members of families considering cochlear implantation. Laryngoscope, 119:131β136, 2009
π SIMILAR VOLUMES
Mutations in the gene of the gap junction protein Connexin 31 (CX31; other connexin 1 Laboratory of Molecular genes abbreviated by CX+#, i.e. Connexin 30 = CX30) have been demonstrated to be Otology, Epstein Laboratories, responsible for both autosomal dominant and recessive nonsyndromic hereditary